Skip to main content

17 December 2025

Last updated: Wednesday 17 December 2025

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

Merck Serono Ventures invests in early technology

Monday 15 June 2009

Interviewee/Contributor

Roel Bulthuis

Organisation

Merck Serono Ventures

Organisations

Idiopathic Pulmonary Fibrosis: Surprise finding in the clinic
BioLizard NV
Noxxon Pharma AG
Bone Therapeutics SA
Novimmune SA
Merck Serono Ventures
TreeFrog Therapeutics SAS
Atrogi AB
4SC AG
CEVEC Pharmaceuticals GmbH

Interviewees and Contributers

Beatriz San Martin
Vincenzo Salvatore
Iain Wilcock
John Mayo
Carlos Buesa
Jennifer Bailey
Tim Edwards
Antoine Papiernik
Karen Finn
Johan Strömquist and Thomas Lönngren

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

Werner Lanthaler appointed CEO of FairJourney Biologics

Thursday 6 November 2025

New CEO at Evaxion

Thursday 6 November 2025

Draig Therapeutics appoints President and CEO

Thursday 6 November 2025

Forbion appoints partner in growth fund

Thursday 6 November 2025

Amphista Therapeutics names executives to drive clinical development

Thursday 6 November 2025

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2025 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form